APA (7th ed.) Citation

Xue, F., Zhao, X., Sun, J., Zeng, X., Yang, F., Xu, M., . . . Yang, R. (2021). Pharmacokinetic, efficacy and safety evaluation of B‐domain‐deleted recombinant FVIII (SCT800) for prophylactic treatment in adolescent and adult patients with severe haemophilia A. Haemophilia, 27(5), 814. https://doi.org/10.1111/hae.14350

Chicago Style (17th ed.) Citation

Xue, Feng, et al. "Pharmacokinetic, Efficacy and Safety Evaluation of B‐domain‐deleted Recombinant FVIII (SCT800) for Prophylactic Treatment in Adolescent and Adult Patients with Severe Haemophilia A." Haemophilia 27, no. 5 (2021): 814. https://doi.org/10.1111/hae.14350.

MLA (9th ed.) Citation

Xue, Feng, et al. "Pharmacokinetic, Efficacy and Safety Evaluation of B‐domain‐deleted Recombinant FVIII (SCT800) for Prophylactic Treatment in Adolescent and Adult Patients with Severe Haemophilia A." Haemophilia, vol. 27, no. 5, 2021, p. 814, https://doi.org/10.1111/hae.14350.